Kuvatris Therapeutics Inc (PXMD) - News Archive

Showing 3 of 3 results.

PaxMedica Appeals Nasdaq Delisting and Prepares for FDA Meeting on PAX-101

New York-based biopharmaceutical company, PaxMedica, Inc. (OTC:PXMD), is currently facing a delisting threat by Nasdaq. In response, PaxMedica has taken swift action by filing an appeal with the Nasdaq Office of Appeals...

May 15, 2024 • Major Pharmaceutical Preparations Industry Announcement PaxMedica

PaxMedica Steps Up to Combat Sleeping Sickness Crisis in Malawi with Emergency Supply of IV Suramin

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101PaxMedica Inc. (Nasdaq: PXMD), a leading biopharmaceutical company dedicated to advancing treatments for neurologi...

Apr 23, 2024 • Major Pharmaceutical Preparations Industry Management Announcement #PXMD

PaxMedica Revolutionizes Autism Spectrum Disorder Treatments with Groundbreaking Innovations

PaxMedica Unveils Innovations in Autism Spectrum Disorder Treatments in Latest Company PresentationTARRYTOWN, New York, March 13, 2024 - PaxMedica, Inc. (NASDAQ: PXMD), a leading biopharmaceutical company specializing i...

Mar 13, 2024 • Major Pharmaceutical Preparations Industry Management Announcement PaxMedica